Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Department of Radiation Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Acta Neurochir (Wien). 2024 May 24;166(1):229. doi: 10.1007/s00701-024-06126-7.
BACKGROUND: Extracorporeal irradiation of tumorous calvaria (EITC) can be performed to restore function and form of the skull after resection of bone-invasive meningioma. We sought to examine the rate of tumour recurrence and other selected outcomes in patients undergoing meningioma resection and EITC. METHODS: Retrospective single-centre study of adult patients undergoing meningioma resection and EITC between January 2015 and November 2022 at a tertiary neurosurgical centre. Patient demographics, surgery data, tumour data, use of adjuvant therapy, surgical complications, and tumour recurrences were collected. RESULTS: Eighteen patients with 11 (61%) CNS WHO grade 1, 6 (33%) grade 2, and 1 (6%) grade 3 meningiomas were included. Median follow-up was 42 months (range 3-88). Five (28%) patients had a recurrence, but none were associated with the bone flap. Two (11%) wound infections requiring explant surgery occurred. Six (33%) patients required a further operation. Two operations were for recurrences, one was for infection, one was a washout and wound exploration but no evidence of infection was found, one patient requested the removal of a small titanium implant, and one patient required a ventriculoperitoneal shunt for a persistent CSF collection. There were no cases of bone flap resorption and cosmetic outcome was not routinely recorded. CONCLUSION: EITC is feasible and fast to perform with good outcomes and cost-effectiveness compared to other reconstructive methods. We observed similar recurrence rates and lower infection rates requiring explant compared to the largest series of cranioplasty in meningioma. Cosmetic outcome is universally under-reported and should be reported in future studies.
背景:在骨侵袭性脑膜瘤切除后,可进行颅外照射肿瘤颅骨(EITC)以恢复颅骨的功能和形态。我们旨在研究接受脑膜瘤切除术和 EITC 的患者的肿瘤复发率和其他选定结果。
方法:回顾性分析 2015 年 1 月至 2022 年 11 月在一家三级神经外科中心接受脑膜瘤切除术和 EITC 的成年患者的单中心研究。收集患者的人口统计学、手术数据、肿瘤数据、辅助治疗的使用、手术并发症和肿瘤复发情况。
结果:18 例患者中,11 例(61%)为中枢神经系统 WHO 分级 1,6 例(33%)为分级 2,1 例(6%)为分级 3 脑膜瘤。中位随访时间为 42 个月(范围 3-88)。5 例(28%)患者复发,但均与骨瓣无关。2 例(11%)发生需要取出植入物的伤口感染。6 例(33%)需要进一步手术。2 次手术为复发,1 次为感染,1 次为冲洗和伤口探查,但未发现感染证据,1 例患者要求取出小钛植入物,1 例患者因持续性 CSF 积聚需要脑室-腹腔分流术。未发生骨瓣吸收病例,且未常规记录美容效果。
结论:与其他重建方法相比,EITC 具有良好的结果和成本效益,且实施快速、可行。与脑膜瘤中最大的颅骨成形术系列相比,我们观察到相似的复发率和较低的需要取出植入物的感染率。美容效果普遍未得到报告,应在未来的研究中报告。
Acta Neurochir (Wien). 2024-5-24
Acta Neurochir (Wien). 2025-6-4
Cochrane Database Syst Rev. 2025-6-9
Acta Neurochir (Wien). 2024-5-14
Cochrane Database Syst Rev. 2025-1-29
J Neurosurg. 2015-5
Cochrane Database Syst Rev. 2025-3-11
Acta Neurochir (Wien). 2023-5
World Neurosurg. 2020-5-6
J Glob Oncol. 2016-3-16